摘要 |
<p>The present invention relates to a ZD6474 monohydrate, to processes for the preparation of a ZD6474 monohydrate, to pharmaceutical compositions comprising a ZD6474 monohydrate as the active ingredient, to the use of a ZD6474 monohydrate in the manufacture of medicaments for use in the production of antiangiogenic and/or vascular permeability reducing effects in warm-blooded animals such as humans, and to the use of a ZD6474 monohydrate in methods for the treatment of disease states associated with angiogenesis and/or increased vascular permeability, such as cancer, in warm-blooded animals such as humans.</p> |
申请人 |
ASTRAZENECA AB;ASTRAZENECA UK LIMITED;BOOTH, REBECCA, JANE;MEYRICK, BRIAN, ROGER;PATEL, ZAKARIYA;STOREY, RICHARD, ANTHONY |
发明人 |
BOOTH, REBECCA, JANE;MEYRICK, BRIAN, ROGER;PATEL, ZAKARIYA;STOREY, RICHARD, ANTHONY |